Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 5301312, 7 pages
https://doi.org/10.1155/2017/5301312
Research Article

Effects of FTY720 on Lung Injury Induced by Hindlimb Ischemia Reperfusion in Rats

Department of Anesthesiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

Correspondence should be addressed to Xiangqing Xiong; nc.ude.umw@gnoixgniqgnaix

Received 21 May 2017; Revised 9 August 2017; Accepted 13 September 2017; Published 9 November 2017

Academic Editor: Elisabetta Albi

Copyright © 2017 Liangrong Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. M. Yassin, D. W. Harkin, D. Barros, A. A. Sa, M. I. Halliday, and B. J. Rowlands, “Lower limb ischemia-reperfusion injury triggers a systemic inflammatory response and multiple organ dysfunction,” World Journal of Surgery, vol. 26, no. 1, pp. 115–121, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. M. D. Bianco-Batlles, A. Sosunov, R. A. Polin, and V. S. Ten, “Systemic inflammation following hind-limb ischemia-reperfusion affects brain in neonatal mice,” Developmental Neuroscience, vol. 30, no. 6, pp. 367–373, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. T. C. Peng, W. C. Jan, P. S. Tsai, and C. J. Huang, “Heme oxygenase-1 mediates the protective effects of ischemic preconditioning on mitigating lung injury induced by lower limb ischemia-reperfusion in rats,” Journal of Surgical Research, vol. 167, no. 2, pp. e245–e253, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. M. C. Kao, W. C. Jan, P. S. Tsai, T. Y. Wang, and C. J. Huang, “Magnesium sulfate mitigates lung injury induced by bilateral lower limb ischemia-reperfusion in rats,” Journal of Surgical Research, vol. 171, no. 1, pp. e97–106, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Y. Hsu, P. S. Tsai, J. J. Lee, T. Y. Wang, and C. J. Huang, “Platonin mitigates acute lung injury induced by bilateral lower limb ischemia-reperfusion in rats,” Journal of Surgical Research, vol. 167, no. 2, pp. e255–e262, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Gao, J. Zhao, H. Kim et al., “α1-Antitrypsin inhibits ischemia reperfusion-induced lung injury by reducing inflammatory response and cell death,” The Journal of Heart and Lung Transplantation, vol. 33, no. 3, pp. 309–315, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Gellings Lowe, J. S. Swaney, K. M. Moreno, and R. A. Sabbadini, “Sphingosine-1-phosphate and sphingosine kinase are critical for transforming growth factor-β-stimulated collagen production by cardiac fibroblasts,” Cardiovascular Research, vol. 82, no. 2, pp. 303–312, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. H. C. Tsai and M. H. Han, “Sphingosine-1-phosphate (S1P) and S1P signaling pathway: therapeutic targets in autoimmunity and inflammation,” Drugs, vol. 76, no. 11, pp. 1067–1079, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Kim, S. W. Park, S. M. Pitson, and H. T. Lee, “Isoflurane protects human kidney proximal tubule cells against necrosis via sphingosine kinase and sphingosine-1-phosphate generation,” American Journal of Nephrology, vol. 31, no. 4, pp. 353–362, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Ding, J. Han, Y. Tian, R. Guo, and X. Ma, “Sphingosine-1-phosphate attenuates lung injury induced by intestinal ischemia/reperfusion in mice: role of inducible nitric-oxide synthase,” Inflammation, vol. 35, no. 1, pp. 158–166, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Mansoor and A. J. Melendez, “Recent trials for FTY720 (fingolimod): a new generation of immunomodulators structurally similar to sphingosine,” Reviews on Recent Clinical Trials, vol. 3, no. 1, pp. 62–69, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. M. L. Stone, A. K. Sharma, Y. Zhao et al., “Sphingosine-1-phosphate receptor 1 agonism attenuates lung ischemia-reperfusion injury,” American Journal of Physiology Lung Cellular and Molecular Physiology, vol. 308, no. 12, pp. 1245–1252, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. D. M. Anselmo, F. F. Amersi, X. D. Shen et al., “FTY720 pretreatment reduces warm hepatic ischemia reperfusion injury through inhibition of T-lymphocyte infiltration,” American Journal of Transplantation, vol. 2, no. 9, pp. 843–849, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Anselmo, F. F. Amersi, X. D. Shen et al., “FTY720: a novel approach to the treatment of hepatic ischemia-reperfusion injury,” Transplantation Proceedings, vol. 34, no. 5, pp. 1467-1468, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Troncoso, M. Ortiz, L. Martinez, and B. D. Kahan, “FTY 720 prevents ischemic reperfusion damage in rat kidneys,” Transplantation Proceedings, vol. 33, no. 1-2, pp. 857–859, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Q. Xiong, L. N. Lin, L. R. Wang, and L. D. Jin, “Sevoflurane attenuates pulmonary inflammation and ventilator-induced lung injury by upregulation of HO-1 mRNA expression in mice,” International Journal of Nanomedicine, vol. 8, no. 1, pp. 1075–1081, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. P. S. Barie and R. J. Mullins, “Experimental methods in the pathogenesis of limb ischemia,” Journal of Surgical Research, vol. 44, no. 3, pp. 284–307, 1988. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Gyurkovics, P. Aranyi, R. Stangl et al., “Postconditioning of the lower limb—protection against the reperfusion syndrome,” Journal of Surgical Research, vol. 169, no. 1, pp. 139–147, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Brinkmann, “FTY720: mechanism of action and potential benefit in organ transplantation,” Yonsei Medical Journal, vol. 45, no. 6, pp. 991–997, 2004. View at Publisher · View at Google Scholar
  20. D. T. Bolick, S. Srinivasan, K. W. Kim et al., “Sphingosine-1-phosphate prevents tumor necrosis factor-α-mediated monocyte adhesion to aortic endothelium in mice,” Arteriosclerosis Thrombosis and Vascular Biology, vol. 25, no. 5, pp. 976–981, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. A. J. Melendez, “Sphingosine kinase signalling in immune cells: potential as novel therapeutic targets,” Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, vol. 1784, no. 1, pp. 66–75, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Camerer, J. B. Regard, I. Cornelissen et al., “Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice,” The Journal of Clinical Investigation, vol. 119, no. 7, pp. 1871–1879, 2009. View at Publisher · View at Google Scholar
  23. F. Roviezzo, B. D'Agostino, V. Brancaleone et al., “Systemic administration of sphingosine-1-phosphate increases bronchial hyperresponsiveness in the mouse,” American Journal of Respiratory Cell and Molecular Biology, vol. 42, no. 5, pp. 572–577, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Idzko, H. Hammad, M. van Nimwegen et al., “Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function,” The Journal of Clinical Investigation, vol. 116, no. 11, pp. 2935–2944, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. L. P. Vlasenko and A. J. Melendez, “A critical role for sphingosine kinase in anaphylatoxin-induced neutropenia, peritonitis, and cytokine production in vivo,” The Journal of Immunology, vol. 174, no. 10, pp. 6456–6461, 2005. View at Publisher · View at Google Scholar
  26. W. Q. Lai, H. H. Goh, Z. Bao, W. S. Wong, A. J. Melendez, and B. P. Leung, “The role of sphingosine kinase in a murine model of allergic asthma,” The Journal of Immunology, vol. 180, no. 6, pp. 4323–4329, 2008. View at Publisher · View at Google Scholar
  27. N. J. Pyne and S. Pyne, “Sphingosine 1-phosphate and cancer,” Nature Reviews Cancer, vol. 10, no. 7, pp. 489–503, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. S. W. Paugh, S. G. Payne, S. E. Barbour, S. Milstien, and S. Spiegel, “The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2,” FEBS Letters, vol. 554, no. 1-2, pp. 189–193, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Zemann, B. Kinzel, M. Muller et al., “Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720,” Blood, vol. 107, no. 4, pp. 1454–1458, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. P. P. Van Veldhoven and G. P. Mannaerts, “Subcellular localization and membrane topology of sphingosine-1-phosphate lyase in rat liver,” Journal of Biological Chemistry, vol. 266, no. 19, pp. 12502–12507, 1991. View at Google Scholar
  31. P. Bandhuvula, Y. Y. Tam, B. Oskouian, and J. D. Saba, “The immune modulator FTY720 inhibits sphingosine-1-phosphate lyase activity,” Journal of Biological Chemistry, vol. 280, no. 40, pp. 33697–33700, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Abraham, “Neutrophils and acute lung injury,” Critical Care Medicine, vol. 31, Supplement 4, pp. S195–S199, 2003. View at Publisher · View at Google Scholar
  33. M. Suleiman, P. M. Cury, J. O. Pestana, E. A. Burdmann, and V. Bueno, “FTY720 prevents renal T-cell infiltration after ischemia/reperfusion injury,” Transplantation Proceedings, vol. 37, no. 1, pp. 373-374, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. A. S. Awad, H. Ye, L. Huang, L. Li, and F. W. Foss JrT. L. Macdonald, K. R. Lynch, and M. D. Okusa, “Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney,” American Journal of Physiology Renal Physiology, vol. 290, no. 6, pp. F1516–F1524, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Dragun, T. Bohler, M. Nieminen-Kelha et al., “FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injury,” Kidney International, vol. 65, no. 3, pp. 1076–1083, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Downes, Y. J. Chen, A. Kyles, and C. Gregory, “Oral pharmacokinetic and pharmacodynamic effects of FTY720 in cats,” Journal of Veterinary Pharmacology and Therapeutics, vol. 30, no. 1, pp. 55–61, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. R. M. Zwacka, Y. Zhang, J. Halldorson, H. Schlossberg, L. Dudus, and J. F. Engelhardt, “CD4+ T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver,” Journal Clinical Investigation, vol. 100, no. 2, pp. 279–289, 1997. View at Publisher · View at Google Scholar
  38. M. Frink, C. P. Kaudel, F. Hildebrand et al., “FTY720 improves survival after transient ischemia and reperfusion of the hind limbs,” The Journal of Trauma and Care Surgery, vol. 63, no. 2, pp. 263–267, 2007. View at Publisher · View at Google Scholar · View at Scopus